NASDAQ:ASND - Ascendis Pharma A/S SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$126.36 +2.20 (+1.77 %)
(As of 05/21/2019 04:00 PM ET)
Previous Close$124.16
Today's Range$125.00 - $127.34
52-Week Range$53.21 - $131.76
Volume212,089 shs
Average Volume356,029 shs
Market Capitalization$5.32 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.94

SEC Filings

Ascendis Pharma A/S (NASDAQ:ASND) SEC Filings

DateFilerForm TypeView
05/16/2019
3:24 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/01/2019
3:15 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/19/2019
3:16 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/12/2019
4:27 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/03/2019
3:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/14/2019
4:16 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/12/2019
4:19 PM
Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
03/08/2019
3:10 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/06/2019
4:23 PM
Ascendis Pharma A/S (Filer)
Form 424B5
View Filing
03/04/2019
3:39 PM
Ascendis Pharma A/S (Filer)
Form 424B5
View Filing
03/04/2019
5:31 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/01/2019
8:01 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2019
12:51 PM
Ascendis Pharma A/S (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
View Filing
02/14/2019
10:41 AM
Ascendis Pharma A/S (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
3:29 PM
Ascendis Pharma A/S (Subject)
BAKER BROS. ADVISORS LP (Filed by)
Form SC 13G/A
View Filing
02/13/2019
10:42 AM
Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
02/11/2019
3:51 PM
Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
View Filing
02/11/2019
3:50 PM
Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
View Filing
02/08/2019
4:22 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/08/2019
4:21 PM
Ascendis Pharma A/S (Filer)
Form 424B5
View Filing
01/11/2019
2:54 PM
Ascendis Pharma A/S (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
Form SC 13D/A
View Filing
01/10/2019
4:20 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/07/2019
10:02 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/07/2019
8:06 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/04/2019
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/14/2018
3:13 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/07/2018
4:22 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/28/2018
3:13 PM
Ascendis Pharma A/S (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
11/28/2018
3:08 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/16/2018
3:39 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/08/2018
3:11 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/02/2018
4:01 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/12/2018
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/03/2018
3:04 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/02/2018
5:04 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/13/2018
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/12/2018
4:13 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/29/2018
3:44 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/17/2018
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
08/13/2018
3:02 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/12/2018
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/29/2018
3:08 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/15/2018
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/15/2018
3:04 PM
Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
06/06/2018
4:25 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/31/2018
3:05 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/30/2018
3:10 PM
Ascendis Pharma A/S (Filer)
Form F-3ASR
View Filing
05/30/2018
3:05 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/09/2018
4:00 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/03/2018
2:08 PM
Ascendis Pharma A/S (Filer)
Form CT ORDER
View Filing
05/01/2018
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/12/2018
4:12 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/28/2018
3:17 PM
Ascendis Pharma A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
03/28/2018
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/15/2018
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/26/2018
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/21/2018
8:39 PM
Ascendis Pharma A/S (Filer)
Form F-3MEF
View Filing
02/20/2018
4:16 PM
Ascendis Pharma A/S (Filer)
Form 424B5
View Filing
02/20/2018
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/15/2018
4:04 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
02/14/2018
1:50 PM
Ascendis Pharma A/S (Subject)
Sofinnova Capital V FCPR (Filed by)
Form SC 13D/A
View Filing
02/13/2018
3:30 PM
Ascendis Pharma A/S (Subject)
BAKER BROS. ADVISORS LP (Filed by)
Form SC 13G
View Filing
02/13/2018
8:49 AM
Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
Form SC 13G/A
View Filing
01/29/2018
4:29 PM
Ascendis Pharma A/S (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
01/10/2018
3:13 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/08/2018
7:02 AM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/03/2018
3:37 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/29/2017
3:19 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/29/2017
3:17 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/20/2017
3:06 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/14/2017
3:07 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/28/2017
8:00 PM
Ascendis Pharma A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 5/21/2019 by MarketBeat.com Staff

Featured Article: What is the NASDAQ?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel